Efficacy of serum chitotriosidase activity in early treatment of patients with active tuberculosis and a negative sputum smear
Open Access
- 1 August 2012
- journal article
- Published by Taylor & Francis in Therapeutics and Clinical Risk Management
- Vol. 8, 369-72
Abstract
Peer reviewed article authored by (Tasci C, Tapan S, Ozkaya S, Demirer E, Deniz O, Balkan A, Ozkan M, Inan I, Kurt I, Bilgic H). Read article or submit your manuscript for publishing.Keywords
This publication has 12 references indexed in Scilit:
- Chitotriosidase Activity in the Serum of Patients with Sarcoidosis and Pulmonary TuberculosisRespiration, 2007
- Relationships between Serum Markers of Monocyte/Macrophage Activation in Type 1 Gaucher's DiseaseClinical Chemistry and Laboratory Medicine (CCLM), 2002
- Identifying Pulmonary Tuberculosis in Patients With Negative Sputum Smear ResultsChest, 2001
- Chitotriosidase genotype and serum activity in subjects with combined hyperlipidemia: Effect of the lipid-lowering agents, atorvastatin and bezafibrateMetabolism, 2001
- Accuracy and Utility of Commercially Available Amplification and Serologic Tests for the Diagnosis of Minimal Pulmonary TuberculosisAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Immunologic diagnosis of tuberculosis: a reviewTubercle and Lung Disease, 2000
- Synthesis, Sorting, and Processing into Distinct Isoforms of Human Macrophage ChitotriosidaseEuropean Journal of Biochemistry, 1997
- Serodiagnosis of tuberculosis: Detection of mycobacterial antibodies and antigensTubercle and Lung Disease, 1996
- Elevated plasma chitotriosidase activity in various lysosomal storage disordersJournal of Inherited Metabolic Disease, 1995
- Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease.Journal of Clinical Investigation, 1994